Prolab

Beta Alanine Extreme

C-
N+ Score67
ProteinServing: 2 Capsule(s)Type: Amino acid/Protein

Prolab Beta Alanine Extreme is an Amino acid/Protein supplement containing 2 ingredients, primarily focused on athletic performance. The product delivers 3200mg of CarnoSyn® Beta-Alanine, which is provided at a clinically studied dose known to support muscle endurance and reduce fatigue. It also includes 300mg of L-Histidine. This supplement achieved an N+ Score of 67, corresponding to a C- grade, indicating an average but targeted formulation. Its strength lies in delivering a key performance ingredient at an effective dosage. This product is well-suited for athletes and individuals looking to enhance high-intensity exercise capacity.

About This Product

Beta Alanine Extreme by Prolab is a protein supplement containing 2 active ingredients. It has earned an N+ Score of 67/100 (Grade C-).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include CarnoSyn.

N+ Score Breakdown

Ingredient Adequacy100/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness0/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity58/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (2 ingredients)

IngredientAmountDose Adequacy
CarnoSyn3200.000 mgHigh
L-Histidine300.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.